Deutsche Bank’s Tonix Pharmaceuticals TNXP Stock Holding History

Deutsche Bank’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Buy	12,548 +387	+3%	+$4.99K	﹤0.01%	3346
2026 Q1	$167K	Buy	12,161 +11,654	+2,299%	+$179K	﹤0.01%	3074
2025 Q4	$7.92K	Sell	507 -5,390	-91%	-$99.4K	﹤0.01%	3556
2025 Q3	$142K	Buy	5,897 +759	+15%	+$28.2K	﹤0.01%	3215
2025 Q2	$185K	Buy	+5,138	New	+$135K	﹤0.01%	3011
2022 Q3	–	Sell	-4	Closed	-$123K	–	4072
2022 Q2	$123K	Buy	+4	New	+$295K	﹤0.01%	3416
2022 Q1	–	Hold	0	–	–	–	3809
2021 Q4	–	Sell	-1	Closed	-$318K	–	3727
2021 Q3	$225K	Buy	+1	New	+$487K	﹤0.01%	3509
2021 Q2	–	Hold	0	–	–	–	3746
2019 Q4	–	Hold	0	–	-$11K	–	5135
2019 Q3	–	Hold	0	–	–	–	4484
2019 Q2	–	Hold	0	–	–	–	5240
2019 Q1	–	Hold	0	–	–	–	4970
2017 Q3	–	Hold	0	–	-$8K	–	5081
2017 Q2	–	Hold	0	–	–	–	4696
2016 Q2	–	Hold	0	–	-$11K	–	5350
2016 Q1	–	Hold	0	–	–	–	4801
2015 Q4	–	Hold	0	–	–	–	4624
2015 Q3	–	Hold	0	–	–	–	4672
2015 Q2	–	Hold	0	–	–	–	3797
2015 Q1	–	Hold	0	–	–	–	3596
2014 Q4	–	Hold	0	–	–	–	5965

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SIC

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Deutsche Bank's TNXP Position: Q2 2026 in Review

Deutsche Bank increased its Tonix Pharmaceuticals (TNXP) stake by 3.2% in Q2 2026, buying an estimated $4.99K and bringing the position to 12,548 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #3346.

Deutsche Bank first reported a position in TNXP in Q3 2021 and has held it in 7 quarters since. The position peaked at $225K in Q3 2021. 31 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

Deutsche Bank held 12,548 shares of Tonix Pharmaceuticals worth $160K as of Q2 2026.
Deutsche Bank bought 387 Tonix Pharmaceuticals shares in Q2 2026, an estimated $4.99K.
Tonix Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3346 holding.
Deutsche Bank first reported a position in Tonix Pharmaceuticals in Q3 2021 and has held it in 7 quarters since.
Deutsche Bank's Tonix Pharmaceuticals position peaked at $225K in Q3 2021.
31 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.